Phaneth Keo, PharmaD
Vice President, Medical Science Liaisons and Medical Strategies for Innovative Therapies, Fresenius Medical Care, Renal Therapies Group

Since joining the Medical Affairs Department at Fresenius Medical Care Renal Therapies Group in 2007, Phaneth has managed the activities of the US Medical Science Liaison team. Additionally, Phaneth has been involved in various strategic initiatives involving the RTG portfolio, Global Research and Development predevelopment projects, and FMCNA. Phaneth received her doctorate from the Medical College of Virginia School of Pharmacy and completed a postdoctoral fellowship with Rutgers University Ernest Mario School of Pharmacy and Bristol Myers Squibb.


COVID-19 Vaccines: Critical New Tools In The Fight Against The Global Pandemic